Adaptin Bio APTN Cash Flow Statement (2023-2026)

OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT
Reported Financials

Adaptin Bio Quarterly Cash Flow Statement

Periods 12 quarters
Latest Jun 2026

Adaptin Bio reported cash from operations of -$0.45M and free cash flow of -$0.45M for the quarter ended Jun 2026, up 56.0% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -0.04M-0.03M-0.34M-0.82M-1.11M-0.86M-0.60M-1.52M-1.68M-1.40M-1.15M-1.21M
Share-based CompensationStock Comp. 1.43M-0.07M1.48M2.29M
Gains from Investment SecuritiesGains Investment 133.000.00M0.01M0.01M0.01M1.43M0.02M
Cash from OperationsCash from Ops. -0.06M-0.09M-0.20M-0.47M0.11M-2.28M-1.02M-0.77M-0.70M-0.60M-0.45M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.03M0.02M0.08M0.11M0.05M
Change in Working Capital
Change in Account PayablesChange Payables 0.00M0.00M0.28M-0.07M0.44M0.43M-0.69M0.34M0.67M0.17M-0.14M0.26M
Change in Accured ExpensesChange Accured Exp. -0.03M-0.07M0.64M0.08M0.20M-0.27M-0.26M820.000.07M0.26M-0.04M
Financing Activities
Other financing activitiesOther financing 6.16M1.00M
Cash from Financing ActivitiesCash from Financing 0.06M0.09M0.22M0.56M-0.19M4.62M0.58M0.44M0.82M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued 0.16M1.48M1.53M
Net Equity Issued and RepurchasedNet Equity Issued 6.16M0.65M0.26M
Additional items
Change in Cash 305.000.02M0.09M-0.08M2.34M-1.02M-0.77M-0.12M-0.16M0.37M
Free Cash FlowFCF -0.06M-0.09M-0.20M-0.47M0.11M-2.28M-1.02M-0.77M-0.70M-0.60M-0.45M
Net Cash FlowNCF 305.000.02M0.09M-0.08M2.34M-1.02M-0.77M-0.12M-0.16M0.37M